SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-119135
Filing Date
2020-04-24
Accepted
2020-04-24 16:30:03
Documents
2
Group Members
NESTLE S.A.NESTLE US HOLDCO, INC.NIMCO US, INC.SOCIETE DES PRODUITS NESTLE S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d922306dsc13da.htm SC 13D/A 129646
2 EX-99.1 d922306dex991.htm EX-99.1 7828
  Complete submission text file 0001193125-20-119135.txt   139301
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88972 | Film No.: 20815456
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NESTLE USA, INC. 800 NORTH BRAND BLVD. GLENDALE CA 91203
Business Address C/O NESTLE USA, INC. 800 NORTH BRAND BLVD. GLENDALE CA 91203 (818) 548-7050
Nestle Health Science US Holdings, Inc. (Filed by) CIK: 0001644164 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A